Stock photo depicting Alzheimer's care or research

At Alzheimer’s Research Australia, a passionate and dedicated team is working tirelessly to make a profound impact in the fight against Alzheimer’s disease.

As we invite you to meet our team, we also encourage you to be a part of our journey to make a positive impact on the lives affected by Alzheimer’s disease.

Alzheimer’s Research Australia partners with researchers from: Edith Cowan University, Murdoch University, The University of Western Australia and Macquarie University. Together, with our national and international collaborators we are advancing towards a world where Alzheimer’s is detected early, prevented effectively, and treated successfully.

Our Executive Team
Our executive team, led by CEO Professor Vicky Vass and Director of Research Professor Ralph Martins, AO is the driving force behind our research efforts. Their vision and leadership guide our organisation, ensuring that we stay at the forefront of Alzheimer’s research.

Our Research Team
Our esteemed research team is dedicated to pioneering new scientific research including early-stage dementia detection, and preventive strategies against the decline of memory and thinking. Our researchers actively engage in national and international initiatives, boasting substantial portfolios of peer-reviewed publications, resulting in high quality outcomes that secures results for the community.

Our Clinical Trials Team
Our clinical trials team is focused on conducting trials for new pharmaceutical treatments being developed to treat Alzheimer’s disease. This provides the opportunity for people at risk of Alzheimer’s, or with an early diagnosis, to trial new potential treatments which may assist in slowing or halting disease progression. The team is led by a very experienced manager, Helen Daniels, together with Neurologist Dr Daniel Clarke.

Our Board
Our distinguished Board members provide strategic guidance and leadership, shaping the future of Alzheimer’s Research Australia. Their commitment to our mission is invaluable in guiding our organisation towards a world without Alzheimer’s.

Our Research Support Team
Our Research Support team comprises a cohesive and dedicated group with diverse skills that support our mission. They are responsible for fundraising, facilities management, public education events, and communication. This team’s commitment and expertise fosters an environment that enables researchers to concentrate on their research and its impact.

Chief Executive Officer

Professor Vicky Vass BA (Hons), PhD

Professor Vass is an experienced CEO and academic. She exemplifies a tri-sectoral leader, having skilfully navigated the complexities of Not-For-Profit, tertiary education, and private industry. Her extensive experience and exceptional leadership transcend these sectors, leaving a lasting mark on the global landscape of education, research, and governance. Renowned for her ability to forge meaningful collaborations, she has played a pivotal role in health and medical communities in both the UK and Australia, fostering ties with government entities to drive comprehensive initiatives. Vicky adeptly weaves her multifaceted leadership approach into providing a comprehensive perspective that emphasises her steadfast dedication to advancing research, cultivating partnerships, and enhancing effective governance in alignment with the mission of Alzheimer’s Research Australia.

Alzheimer’s Research Australia Board of Directors

Chair – Graeme Prior, AM FCA

Chief Executive Officer – Hall & Prior Aged Care Group

Graeme Prior joined the board in 2019 and brings over 30 years of leadership experience in the aged care sector. As the CEO of Hall & Prior Residential Health and Aged Care Group, he oversees the care of thousands of residential and community clients across Perth and Sydney. Graeme is a passionate advocate for improving the quality of aged care services through education, technology, and workforce enablement. He holds numerous leadership roles in national and international aged-care organisations.

Deputy Chair – Dr Terry Bayliss

Coordinator Development, Projects & Research – Ramsay Health Care

Dr Terry Bayliss has been a board member of Alzheimer’s Research Australia since its inception in 2000 and previously served as Chair in 2005. He has over 40 years of experience in medicine and hospital management. Dr Bayliss is also Chair of the Hollywood Private Hospital Human Research Ethics Committee and heads the Hollywood Private Hospital Research Foundation, which has funded over $1 million in research grants. He is passionate about advancing medical research in the private hospital and not-for-profit sectors​

Director of Research – Professor Ralph Martins, AO 

Professor of Neurobiology – Macquarie University & Foundation Chair of Ageing and Alzheimer’s disease – Edith Cowan University

Professor Ralph Martins has been a board member of Alzheimer’s Research Australia since its inception in 2000 and is internationally renowned for his work in Alzheimer’s disease research, having dedicated over four decades to studying the disease. He is the Foundation Professor of Ageing and Alzheimer’s Disease at Edith Cowan University and ARAs’ Director of Research. Professor Martins’ groundbreaking research has focused on early diagnosis and preventative strategies, and he has contributed to major global studies and trials. In recognition of his work, he was awarded Officer of the Order of Australia (AO) in 2013.

Dr Pamela Cresswell

Adjunct Professor in Nursing – Curtin University

Dr Pamela Cresswell joined the board in 2023 and brings over 30 years of leadership experience in education and health. She has held executive roles at Curtin University, where she oversaw financial management, governance, and the strategic development of the School of Nursing. Pamela has extensive experience in managing complex international programs and ensuring compliance with regulatory standards. She has served on multiple boards, including the Nurses Board of Western Australia and Tennis West, and is a graduate of the Australian Institute of Company Directors.

Professor Colin Masters, AO

Laureate Professor of Dementia Research – The Florey Institute and the University of Melbourne

Professor Colin Masters joined the board in 2023 and has over 40 years of experience in Alzheimer’s disease research. He is a Professor of Dementia Research at the Florey Institute of Neuroscience and Mental Health and has made significant contributions to understanding the pathology of neurodegenerative diseases. His research, particularly his collaboration with Konrad Beyreuther, identified the Aβ amyloid protein responsible for Alzheimer’s disease. Professor Masters’ work has been foundational in developing diagnostic and therapeutic strategies, and he has been recognised with numerous international awards for his achievements in the field.

Enzo Sirna, AM

President of the Italo-Australian Welfare and Cultural Centre

Enzo Sirna joined the board in 2000, bringing extensive educational and cultural leadership experience. He has been deeply involved in the Italian-Australian community as President of the Italo-Australian Welfare & Cultural Centre Inc. Enzo has held various leadership roles on state and national committees. He was awarded the Order of Merit of the Italian Republic (Cavaliere) and made a Member of the Order of Australia (AM) for his contributions to the community

About us

Meet the Research Leadership Team

There are currently around 90 people who work regularly in our state-of-the-art facilities dedicated to Alzheimer’s research. These include researchers, students and research interns from many collaborating universities, as well as international students.

The research team is involved in both clinical and laboratory-based research projects. This includes everything from interviewing study participants and collection of blood samples, to conducting laboratory work and ensuring the safe long-term storage of vital data and samples.

The Research Leadership Team covers a broad range of projects to better understand Alzheimer’s disease, and develop preventative strategies and innovative ways to diagnose the disease so treatments can be implemented as early as possible.